Enterprise Bank & Trust Co lowered its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Get Rating) by 7.8% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,221 shares of the medical research company’s stock after selling 523 shares during the quarter. Thermo Fisher Scientific accounts for about 1.4% of Enterprise Bank & Trust Co’s holdings, making the stock its 17th largest position. Enterprise Bank & Trust Co’s holdings in Thermo Fisher Scientific were worth $3,674,000 at the end of the most recent reporting period.
Other institutional investors also recently added to or reduced their stakes in the company. Widmann Financial Services Inc. bought a new stake in Thermo Fisher Scientific in the 4th quarter valued at $26,000. Mystic Asset Management Inc. acquired a new position in shares of Thermo Fisher Scientific in the 4th quarter valued at $29,000. Lee Financial Co acquired a new position in shares of Thermo Fisher Scientific in the 4th quarter valued at $32,000. Costello Asset Management INC acquired a new position in shares of Thermo Fisher Scientific in the 4th quarter valued at $33,000. Finally, Sumitomo Mitsui Financial Group Inc. raised its stake in shares of Thermo Fisher Scientific by 141.7% in the 4th quarter. Sumitomo Mitsui Financial Group Inc. now owns 58 shares of the medical research company’s stock valued at $38,000 after buying an additional 34 shares in the last quarter. Hedge funds and other institutional investors own 87.48% of the company’s stock.
In other Thermo Fisher Scientific news, COO Michel Lagarde sold 17,150 shares of the business’s stock in a transaction dated Tuesday, May 24th. The stock was sold at an average price of $548.30, for a total transaction of $9,403,345.00. Following the completion of the transaction, the chief operating officer now owns 15,758 shares of the company’s stock, valued at $8,640,111.40. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Marc N. Casper sold 10,000 shares of the business’s stock in a transaction dated Monday, May 2nd. The stock was sold at an average price of $545.60, for a total value of $5,456,000.00. Following the transaction, the chief executive officer now directly owns 183,373 shares of the company’s stock, valued at approximately $100,048,308.80. The disclosure for this sale can be found here. Insiders have sold 42,561 shares of company stock valued at $23,557,413 in the last ninety days. 0.43% of the stock is currently owned by company insiders.
TMO stock opened at $519.22 on Thursday. The company has a fifty day moving average price of $544.31 and a two-hundred day moving average price of $575.26. The stock has a market cap of $203.25 billion, a price-to-earnings ratio of 27.07, a price-to-earnings-growth ratio of 1.70 and a beta of 0.83. Thermo Fisher Scientific Inc. has a one year low of $489.14 and a one year high of $672.34. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.56 and a quick ratio of 1.10.
Thermo Fisher Scientific (NYSE:TMO – Get Rating) last announced its earnings results on Thursday, April 28th. The medical research company reported $7.25 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.17 by $1.08. Thermo Fisher Scientific had a net margin of 18.49% and a return on equity of 25.33%. The company had revenue of $11.82 billion during the quarter, compared to analysts’ expectations of $10.66 billion. During the same quarter in the previous year, the business posted $7.21 earnings per share. Thermo Fisher Scientific’s quarterly revenue was up 19.3% on a year-over-year basis. Research analysts anticipate that Thermo Fisher Scientific Inc. will post 22.7 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 15th. Investors of record on Wednesday, June 15th will be given a dividend of $0.30 per share. The ex-dividend date of this dividend is Tuesday, June 14th. This represents a $1.20 annualized dividend and a yield of 0.23%. Thermo Fisher Scientific’s dividend payout ratio is 6.26%.
Thermo Fisher Scientific Profile (Get Rating)
Thermo Fisher Scientific Inc offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
- Get a free copy of the StockNews.com research report on Thermo Fisher Scientific (TMO)
- Victoria’s Secret Stock is Out of the Box
- Downturn Gives These 3 Buys Juicy Dividend Yields
- Time For a Ride in Six Flags Stock
- Why Dollar General (NYSE: DG) Should Be In Your Portfolio
- Korn Ferry Is A Good Buy For The Recession And Beyond
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.